Congenica

OverviewSuggest Edit

Congenica is a UK start-up company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and genetic testing laboratories. We are translating this research into a revolutionary clinical genomic analytics platform, Sapientia, for processing genome-wide data sets of human DNA sequence with deep clinical phenotype information in order to provide a definitive molecular diagnosis and clinically actionable interpretation for treatment, patient stratification and improved therapeutic discoveries.

TypePrivate
Founded2014
Websitecongenica.com

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)74(+2%)

Key People/Management at Congenica

David Atkins

David Atkins

CEO
Nick Lench

Nick Lench

Chief Scientific Officer
Andy Richards

Andy Richards

Chairman
Matthew Hurles

Matthew Hurles

Scientific Director
David Shi

David Shi

Investment Director
Michael Anstey

Michael Anstey

Investment Director
Show more

Congenica Office Locations

Congenica has an office in Hinxton
Hinxton, GB
Wellcome Genome Campus
Show all (1)

Congenica Financials and Metrics

Summary Metrics

Founding Date

2014

Congenica total Funding

$32.2 m

Congenica latest funding size

$17.45 m

Time since last funding

9 months ago

Congenica investors

Congenica's latest funding round in April 2019 was reported to be $17.5 m. In total, Congenica has raised $32.2 m
Show all financial metrics

Congenica Online and Social Media Presence

Embed Graph

Congenica News and Updates

Congenica makes Atkins its CEO

Congenica said Jan. 25 that it named David Atkins, Ph.D, as its new CEO. Dr Atkins was previously CEO of Synevo.

Congenica Blogs

Congenica launches new application to enable faster analysis of epilepsy and neurodevelopmental disorders

Cambridge, United Kingdom – 14th January, 2020 – Congenica, a digital health company enabling rapid analysis of complex genomic data to improve disease characterization... The post Congenica launches new application to enable faster analysis of epilepsy and neurodevelopmental disorders appeared firs…

Download Congenica Neuro Datasheet

* indicates required First Name * Last Name * Email Address * Company * Country * The post Download Congenica Neuro Datasheet appeared first on Congenica.

Re-annotation of Developmental and Epileptic Encephalopathy-associated genes unmasks de novo variants

The developmental and epileptic encephalopathies are a group of rare, severe neurodevelopmental disorders, where even after the most thorough sequencing investigations, 60-65% of patients... The post Re-annotation of Developmental and Epileptic Encephalopathy-associated genes unmasks de novo variant…

Re-annotation of 191 developmental and epileptic encephalopathy-associated genes unmasks de novo variants in SCN1A

Cambridge, United Kingdom – 3rd December, 2019 – Congenica Ltd, a digital health company enabling rapid analysis of complex genomic data to improve disease... The post Re-annotation of 191 developmental and epileptic encephalopathy-associated genes unmasks de novo variants in SCN1A appeared first on…

Maximizing NGS lab efficiency in the analysis and interpretation of genomic data

Maximizing NGS lab efficiency in the analysis and interpretation of next-generation sequencing (NGS) data is essential to be able to deliver fast turnarounds of results and value... The post Maximizing NGS lab efficiency in the analysis and interpretation of genomic data appeared first on Congenica.

A fast and reliable method to reach a conclusive diagnosis of MYH9-related disorder

Congenica platform provides variant review and assessment to support conclusive diagnoses for patients with complex and commonly misdiagnosed bleeding disorders in a large multicenter... The post A fast and reliable method to reach a conclusive diagnosis of MYH9-related disorder appeared first on Co…
Show more

Congenica Frequently Asked Questions

  • When was Congenica founded?

    Congenica was founded in 2014.

  • Who are Congenica key executives?

    Congenica's key executives are David Atkins, Nick Lench and Andy Richards.

  • How many employees does Congenica have?

    Congenica has 74 employees.

  • Who are Congenica competitors?

    Competitors of Congenica include Gemini Therapeutics, Senti Biosciences and Phosphorus.

  • Where are Congenica offices?

    Congenica has an office in Hinxton.

  • How many offices does Congenica have?

    Congenica has 1 office.